[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-343237-105":3,"doc-detail-343237-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","metdecode-methylation-based-deconvolution-of-cell-free-dna-for-noninvasive-multi-cancer-typing","MetDecode - methylation-based deconvolution of cell-free DNA for noninvasive multi-cancer typing","","Circulating cell-free DNA (cfDNA) serves as a noninvasive biomarker for cancer screening and diagnosis, but decoding the cellular origin in cfDNA is challenging and limits biological interpretation and clinical decision-making. MetDecode introduces a DNA methylation signature-based deconvolution approach for identifying cancer tissue origin from cfDNA profiles. It uses a reference methylation atlas and learns missing contributors on the fly, modeling marker coverage to reduce noise. In silico and patient plasma data show strong performance and accurate tissue-of-origin assignment.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/metdecode-methylation-based-deconvolution-of-cell-free-dna-for-noninvasive-multi-cancer-typing/343237/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/metdecode-methylation-based-deconvolution-of-cell-free-dna-for-noninvasive-multi-cancer-typing/343237.png","ImageObject",300,407,{"name":42,"@type":43},"Levi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-15","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",16,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does MetDecode address in cfDNA cancer testing?","Question",{"text":63,"@type":64},"It targets the inability of cfDNA-based screening to determine the tumor’s tissue origin and cancer type, by decoding cellular contributors from cfDNA methylation profiles.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does MetDecode estimate tissue-of-origin from cfDNA?",{"text":68,"@type":64},"MetDecode uses a DNA methylation signature-based deconvolution algorithm built on a reference atlas, while learning absent contributors directly from the input cfDNA methylation data.",{"name":70,"@type":61,"acceptedAnswer":71},"What performance does MetDecode achieve?",{"text":72,"@type":64},"Simulation experiments indicate a detection limit down to 2.88% tumor tissue contribution, with high correlation (Pearson > 0.95). In patient plasma profiles, it correctly assigned tissue-of-origin in 84.2% of cases.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},343237,1790472173,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d",8,"Genome analysis  \nMetDecode: methylation-based deconvolution of cell-free DNA for noninvasive multi-cancer typing  \nAntoine Passemiers 1,†, Stefania Tuveri 2,†, Dhanya Sudhakaran2,†, Tatjana Jatsenko2, Tina Laga3,4, Kevin Punie5,6,7, Sigrid Hatse6, Sabine Tejpar8, An Coosemans 9,  \nEls Van Nieuwenhuysen3,4, Dirk Timmerman4, Giuseppe Floris 10, Anne-Sophie Van Rompuy10, Xavier Sagaert10, Antonia Testa11, Daniela Ficherova 12, Daniele Raimondi 1,  \nFrederic Amant3,4,13, Liesbeth Lenaerts3, Yves Moreau 1, Joris R. Vermeesch2, 􀀃  \n1 Dynamical Systems, Signal Processing and Data Analytics (STADIUS), Department of Electrical Engineering, KU Leuven, Leuven, 3001, Belgium 2 Laboratory for Cytogenetics and Genome Research, Department of Human Genetics, KU Leuven, Leuven, 3000, Belgium 3Gynaecological Oncology, Department of Oncology, KU Leuven, Leuven, 3000, Belgium  \n4Gynaecology and Obstetrics, University Hospitals KU Leuven, Leuven, 3000, Belgium 5 Multidisciplinary Breast Centre, University Hospitals Leuven, Leuven, 3000, Belgium  \n6 Laboratory of Experimental Oncology, Department of General Medical Oncology, University Hospitals Leuven, KU Leuven, Leuven, 3000, Belgium 7 Department of Oncology, GZA Ziekenhuis, Antwerp, 2610, Belgium  \n8 Digestive Oncology Unit, University Hospital Gasthuisberg, Leuven, 3000, Belgium  \n9 Laboratory of Tumour Immunology and Immunotherapy, Department of Oncology, Leuven Cancer Institute, KU Leuven, Leuven, 3000, Belgium 10Translational Cell & Tissue Research, Department of Pathology, KU Leuven, Leuven, 3000, Belgium  \n11 Department of Woman, Child and Public Health, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, 00168, Italy 12 Obstetrics and Gynaecology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic 13 Department of Gynaecologic Oncology, Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands  \n􀀃 Corresponding author. Center for Human Genetics, University Hospitals Leuven, KU Leuven, Herestraat 49, Box 602, Leuven 3000, Belgium.  \nE-mail: [joris.vermeesch@kuleuven.be](joris.vermeesch@kuleuven.be)[ ](joris.vermeesch@kuleuven.be)†Equal contribution.  \nAssociate Editor: Peter Robinson  \nAbstract  \nMotivation: Circulating-cell free DNA (cfDNA) is widely explored as a noninvasive biomarker for cancer screening and diagnosis. The ability to decode the cells of origin in cfDNA would provide biological insights into pathophysiological mechanisms, aiding in cancer characterization and directing clinical management and follow-up.  \nResults: We developed a DNA methylation signature-based deconvolution algorithm, MetDecode, for cancer tissue origin identification. We built a reference atlas exploiting de novo and published whole-genome methylation sequencing data for colorectal, breast, ovarian, and cervical cancer, and blood-cell-derived entities. MetDecode models the contributors absent in the atlas with methylation patterns learnt on-the-fly from the input cfDNA methylation profiles. In addition, our model accounts for the coverage of each marker region to alleviate potential sources of noise. In-silico experiments showed a limit of detection down to 2.88% of tumor tissue contribution in cfDNA. MetDecode produced Pearson correlation coefficients above 0.95 and outperformed other methods in simulations ( P \u003C 0 .001; T-test; one-sided) . In plasma cfDNA profiles from cancer patients, MetDecode assigned the correct tissue-of-origin in 84.2% of cases. In conclusion, MetDecode can unravel alterations in the cfDNA pool components by accurately estimating the contribution of multiple tissues, while supplied with an imperfect reference atlas. Availability and implementation: MetDecode is available at [https://github.com/JorisVermeeschLab/MetDecode](https://github.com/JorisVermeeschLab/MetDecode).  \n1 Introduction  \nCell-free DNA (cfDNA) contains the genomic and epigenetic signatures of the cells of origin (Aucamp et al.","cbCaic3WrADlEzKJ","https://ap.wps.com/l/cbCaic3WrADlEzKJ","pdf",9888896,14,"English","# Abstract\n## Motivation\n## Results\n## Methods/Availability","[{\"question\":\"What problem does MetDecode address in cfDNA cancer testing?\",\"answer\":\"It targets the inability of cfDNA-based screening to determine the tumor’s tissue origin and cancer type, by decoding cellular contributors from cfDNA methylation profiles.\"},{\"question\":\"How does MetDecode estimate tissue-of-origin from cfDNA?\",\"answer\":\"MetDecode uses a DNA methylation signature-based deconvolution algorithm built on a reference atlas, while learning absent contributors directly from the input cfDNA methylation data.\"},{\"question\":\"What performance does MetDecode achieve?\",\"answer\":\"Simulation experiments indicate a detection limit down to 2.88% tumor tissue contribution, with high correlation (Pearson \\u003e 0.95). In patient plasma profiles, it correctly assigned tissue-of-origin in 84.2% of cases.\"}]","MetDecode - methylation-based deconvolution of cell-free DNA for noninvasive multi-cancer typing | PDF",1790050381,35,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/872493608ed9607603f31ac7c0172544.webp",983,1272,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7cc9fbaf6a050b4efe00e8ae79120f75.webp",982,1270,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b6be95293f3fc9f9f83ea3c428d9fd5.webp",981,1269,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b33987bcc428edc7f6134992bcfdd740.webp",980,1268,{"code":4,"msg":82,"data":117},[118,122,126,130,135,140,145,148,153,156,160],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":136,"doc_module":4,"doc_module_name":25,"category_name":137,"show_sort_weight":138,"slug":139},6,"Technology",50,"technology",{"id":141,"doc_module":4,"doc_module_name":25,"category_name":142,"show_sort_weight":143,"slug":144},7,"Healthcare",40,"healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":146,"slug":147},30,"research-report",{"id":149,"doc_module":4,"doc_module_name":25,"category_name":150,"show_sort_weight":151,"slug":152},9,"Religion & Spirituality",20,"religion-spirituality",{"id":151,"doc_module":4,"doc_module_name":25,"category_name":154,"show_sort_weight":151,"slug":155},"World Cup","world-cup",{"id":157,"doc_module":4,"doc_module_name":25,"category_name":158,"show_sort_weight":157,"slug":159},10,"Lifestyle","lifestyle",{"id":161,"doc_module":4,"doc_module_name":25,"category_name":162,"show_sort_weight":131,"slug":163},19,"General","general"]